JAKKS Pacific

JAKKS Pacific beat earnings expectations with an adjusted loss per share of $0.17, but missed revenue expectations with $106.7 million. International business grew 42%, while revenue in North America plunged 17%; EMEA delivered its best quarter since 2015. The company reports improved liquidity and highlights international expansion and license launches such as "The Super Mario Galaxy Movie" as drivers for future growth. » More on de.investing.com

Jakks Pacific sets performance-based bonus criteria for 2026: CEO Stephen G. Berman has a base salary of 1,875,000 USD with a maximum bonus of 300%, and CFO John L. Kimble 632,700 USD with up to a 200% bonus. Bonuses are linked to four EBITDA thresholds: 35,587,507 USD, 45,587,507 USD, 55,587,507 USD and 65,587,507 USD; the lowest threshold is 46% above the last twelve-month EBITDA of 24.36 million USD. Bonus payouts increase with higher results and are linearly interpolated between levels; the compensation committee may adjust criteria for extraordinary items or market changes. The company also enters a license agreement with VIZ Media for Naruto toys, which are expected to be released in the U.S. and Canada in spring 2027. » More on de.investing.com

JAKKS Pacific has signed a licensing agreement with VIZ Media to manufacture and market Naruto toys and costumes for the United States and Canada. The product range includes action figures, playsets, role‑play items and costumes, which will be sold through the main toy division and the costume subsidiary Disguise. The items are slated to reach stores in spring 2027; financial terms of the agreement were not disclosed. JAKKS, with a market capitalization of $252 million, had risen 32.6% year‑to‑date. » More on de.investing.com

JAKKS Pacific is partnering with The Hershey Company to develop an eight-piece collection of candy-inspired mini dolls and charms under the "Charming" brand, inspired by brands such as Hershey’s Kisses, Reese’s and Twizzlers. The first Hershey’s Kisses collectibles will be released Dec. 26, 2025 exclusively at CVS; the agreement runs through Dec. 31, 2026 with an extension option. The company recently reported Q3 results below expectations (EPS $1.80 vs. $2.47 expected; revenue $211.2 million) and faces an analyst-expected revenue decline of about 19%. » More on de.investing.com